The Case for Universal Cervical Length Screening to Prevent Preterm Birth: Is it Strong Enough to Change Practice in Canada?

Journal of Obstetrics and Gynaecology Canada

Volumn 34, Issue 12, 2012, Pages 1184-1187

  Hutcheon, Jennifer A ^a   Amanda Skoll, M ^a   Eastabrook, Genevieve D ^a   Lim, Kenneth I ^a   on behalf of the University of British Columbia Division of Maternal Fetal Medicine, ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cervical length measurement; Mass screening; Prenatal ultrasonography; Preterm birth; Progesterone

Indexed keywords

PROGESTERONE; GESTAGEN;

CANADA; CERVICAL LENGTH MEASUREMENT; CLINICAL EFFECTIVENESS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; HUMAN; MEDICAL PRACTICE; META ANALYSIS (TOPIC); NEWBORN MORBIDITY; NEWBORN MORTALITY; NOTE; PRACTICE GUIDELINE; PREMATURE LABOR; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCREENING; SHORT CERVIX; TREATMENT INDICATION; UTERINE CERVIX DISEASE; ARTICLE; DRUG EFFECT; ECHOGRAPHY; FEMALE; MASS SCREENING; METHODOLOGY; PREGNANCY; PREMATURITY; UTERINE CERVIX;

CANADA; CERVICAL LENGTH MEASUREMENT; CERVIX UTERI; FEMALE; HUMANS; MASS SCREENING; PREGNANCY; PREMATURE BIRTH; PROGESTERONE; PROGESTINS;

EID: 84891663909     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)35467-6     Document Type: Note

References (17)

1. Buekens P., Klebanoff M. Preterm birth research: from disillusion to the search for new mechanisms. Paediatr Perinat Epidemiol 2001, 15:159-161.
2. Carey J.C., Klebanoff M.A., Hauth J.C., Hillier S.L., Thom E.A., Ernest J.M., et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 2000, 342:534-540.
3. Hodnett E.D., Fredericks S., Weston J. Support during pregnancy for women at increased risk of low birthweight babies. Cochrane Database Syst Rev 2010, CD000198.
4. Hassan S.S., Romero R., Vidyadhari D., Fusey S., Baxter J.K., Khandelwal M., et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2011, 38:18-31.
5. Romero R., Nicolaides K., Conde-Agudelo A., Tabor A., O'Brien J.M., Cetingoz E., et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol 2012, 206:124 e1-e19.
6. Farine D., Mundle W.R., Dodd J., Basso M., Delisle M.F., Grabowska K. Maternal Fetal Medicine Committee of the Society of Obstetricians and Gynaecologists of Canada. The use of progesterone for prevention of preterm birth. SOGC technical update, No. 202, January, 2008. J Obstet Gynaecol Can 2008, 30:67-71.
7. Fonseca E.B., Celik E., Parra M., Singh M., Nicolaides K.H. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007, 357:462-469.
8. Society of Maternal-Fetal Medicine Publications Committee Progesterone and preterm birth prevention: translating clinical trials data into clinical practice. Am J Obstet Gynecol 2012, 376-386.
9. Campbell S. Universal cervical-length screening and vaginal progesterone prevents early preterm births, reduces neonatal morbidity and is cost saving: doing nothing is no longer an option. Ultrasound Obstet Gynecol 2011, 38:1-9.
10. Combs C.A. Vaginal progesterone for asymptomatic cervical shortening and the case for universal screening of cervical length. Am J Obstet Gynecol 2012, 206:101-103.
11. Cahill A.G., Odibo A.O., Caughey A.B., Stamilio D.M., Hassan S.S., Macones G.A., et al. Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis. Am J Obstet Gynecol 2010, 202:548 e1-8.
12. Werner E.F., Han C.S., Pettker C.M., Buhimschi C.S., Copel J.A., Funai E.F., et al. Universal cervical-length screening to prevent preterm birth:a cost-effectiveness analysis. Ultrasound Obstet Gynecol 2011, 38:32-37.
13. Stone P.R., Chan E.H., McCowan L.M., Taylor R.S., Mitchell J.M. Transabdominal scanning of the cervix at the 20-week morphology scan: comparison with transvaginal cervical measurements in a healthy nulliparous population. Aust N Z J Obstet Gynaecol 2010, 50:523-527.
14. van Os M.A., van der Ven J.A., Kleinrouweler C.E., et al. Preventing preterm birth with progesterone: costs and effects of screening low risk women with a singleton pregnancy for short cervical length, the Triple P study. BMC Pregnancy Childbirth 2011, 11:77.
15. Canadian Institute for Health Information (CIHI) Giving birth in Canada: the costs. Costs of vaginal delivery and Caesarean section were combined, assuming 26.8% Caesarean section rate; costs < 34 weeks have average costs of admission for threatened preterm labour added 2006, Ottawa, ON, Available at: Accessed November 14, 2012. http://www.cihi.ca/CIHI-ext-portal/internet/en/Search/search/search_main_en?q=giving%20birth%20in%20Canada&client=all_results&start=0&num=10&filter=p.
16. CIHI Online Patient Cost Estimator. Case mix groups < 29 weeks 1000 to 1499 g; < 32 to 34 weeks 1500 to 1999 g; < 35 to 36 weeks 2000 to 2499 g; Normal Newborn Singleton Vaginal and Caesarean. Available at: . Accessed November 14, 2012. http://www.cihi.ca/cihi-ext-portal/internet/en/applicationindex/applicationindex/applications_index_main#.
17. Moutquin J., Lalonde A. The cost of prematurity in Canada 1998, Ottawa ON, Canada.